November 30, 2018 in References Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis PJWCreative 0 Like Post 0 Comment Read More
October 26, 2018 in References Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study PJWCreative 0 Like Post 0 Comment Read More
December 28, 2016 in References Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors PJWCreative 0 Like Post 0 Comment Read More
March 15, 2016 in References Single chain antibody fragments with pH dependent binding to FcRn enabled prolonged circulation of therapeutic peptide in vivo PJWCreative 0 Like Post 0 Comment Read More
October 27, 2015 in References Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials PJWCreative 0 Like Post 0 Comment Read More
March 30, 2009 in References Myeloid-derived suppressor cells as regulators of the immune system PJWCreative 0 Like Post 0 Comment Read More
September 5, 2008 in References Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification PJWCreative 0 Like Post 0 Comment Read More
September 18, 2006 in References All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients PJWCreative 0 Like Post 0 Comment Read More
July 3, 2006 in References Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models PJWCreative 0 Like Post 0 Comment Read More
August 5, 2003 in References Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. PJWCreative 0 Like Post 0 Comment Read More
English 
简体中文